copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Drugs (psychoactive) - World Health Organization (WHO) The use of psychoactive drugs without medical supervision is associated with significant health risks and can lead to the development of drug use disorders Drug use disorders, particularly when untreated, increase morbidity and mortality risks for individuals, can trigger substantial suffering and lead to impairment in personal, family, social, educational, occupational or other important
Alcohol, Drugs and Addictive Behaviours Alcohol, Drugs and Addictive Behaviours The Unit works globally to improve health and well-being of populations by articulating, promoting, supporting and monitoring evidence-informed policies, strategies and interventions to reduce the burden associated with alcohol, drugs and addictive behaviours
Obesity: GLP-1 therapies GLP-1 therapies (glucagon-like peptide-1 receptor agonists) are a class of medications that mimic the natural GLP-1 hormone, which helps regulate blood sugar and appetite They were originally used for managing type 2 diabetes, but are now also approved for treating obesity and weight loss Some GLP-1 drugs lower the risk of heart attack, stroke, and heart failure, and reduce the incidence of
Drugs (psychoactive) - World Health Organization (WHO) Substitution maintenance therapy with methadone or buprenorphine improves the health and social performance of opioid-dependent people and decreases the use of illicit drugs and the crime rate Statistics show that investment in prevention pays off well: every dollar invested in drug treatment saves seven dollars in health and social costs
UN Commission approves WHO recommendations to place psychoactive . . . Following recommendations by the World Health Organization (WHO), the United Nations Commission on Narcotic Drugs (CND) has decided to place five new psychoactive substances and one medicine under international control
Antifungal agents in clinical and preclinical development: overview and . . . This report presents the first World Health Organization (WHO) analysis of antifungal agents in preclinical and clinical development It covers systemic antifungal drugs in development worldwide, including label extension and repurposed products, and critically evaluates how well the current pipeline addresses infections caused by WHO fungal priority pathogens
WHO announces landmark changes in treatment of drug-resistant tuberculosis The World Health Organization (WHO) today released its Consolidated guidelines on tuberculosis (TB)- Module 4: treatment and care, consolidating all previous guidelines into a single comprehensive document and introducing significant improvements in treatment options for people with multidrug-resistant or rifampicin-resistant tuberculosis (MDR RR-TB)
WHO recommends injectable lenacapavir for HIV prevention The World Health Organization (WHO) released today new guidelines recommending the use of injectable lenacapavir (LEN) twice a year as an additional pre-exposure prophylaxis (PrEP) option for HIV prevention, in a landmark policy action that could help reshape the global HIV response
Alcohol, Drugs and Addictive Behaviours Psychoactive substances are substances that, when taken in or administered into one's system, affect mental processes, e g cognition or affect This term and its equivalent, psychotropic drug, are the most neutral and descriptive term for the whole class of substances, licit and illicit, of interest to drug policy ‘Psychoactive’ does not necessarily imply dependence-producing, and in